Mapping the human mucosal immune response to respiratory viruses

Mapping the human mucosal immune response
to respiratory viruses

Conventionally, human immune responses have been extensively characterized using blood. Immune cells, though abundant in blood, are also found in various tissues in varying numbers and with locally relevant functional specification. Assessing immune responses in the airways over the course of infection and convalescence is critical to comprehensively mapping immunity to respiratory viral infections including influenza and SARS-CoV-2.

In a study recently published in eLife, Sindhu Vangeti, PhD, and colleagues at the Icahn School of Medicine at Mount Sinai, demonstrated that innate immune cells, like monocytes and dendritic cells, possess unique dynamics defined by location and pathogen. In addition to characterizing immune cells in blood, the team also investigated immune cell distribution and function in the human nasopharynx.

Learn about:

  • Monocytes and dendritic cells in human respiratory viral infections.
  • Studying immune responses in the human airways.
  • Integrating state-of-the-art platforms into conventional study design.

Image of Sindhu Vangeti

Sindhu Vangeti, PhD

Sindhu Vangeti, PhD, is a postdoctoral fellow in Irene Ramos’s viral immunology team in the Stuart C. Sealfon lab at the Icahn School of Medicine at Mount Sinai. Currently, her research focuses on mapping the epigenetic fingerprint of influenza/SARS-CoV-2 exposure and studying mechanisms that lead to durability of vaccine-induced immunity. Dr. Vangeti obtained her doctorate in 2019 at the Karolinska Institutet in the lab of Anna Smed Sörensen, studying human immune responses to influenza and hantavirus infections.

Mapping the human mucosal immune response to respiratory viruses

A presentation by Sindhu Vangeti, PhD

More resources for immunology research

What can proteomics teach us about infectious disease?

Watch webinar

Tech Note:
SomaScan Assay v4.1 signaling in mouse plasma


Case studies:
Massive-scale proteomics for COVID-19

Learn more

White paper:
COVID-19 and the SomaScan® Platform


Search our publications viewer

Search our extensive database of peer-reviewed research on the use of the SomaScan® Platform by entering keywords to narrow your search, such as influenza, COVID, or respiratory.

See publications

Share with colleagues

More webinars

WebinarUtilizing proteomic strategies to uncover novel biomarkers and mechanisms in heart failure 

Plasma proteomics is a powerful approach for discovering novel protein biomarkers of drug toxicity in various disease contexts. One such biomarker in cardiovascular disease is apolipoprotein M (ApoM), which plays a crucial role in lipid metabolism and transport and is known to have both anti-inflammatory and cardioprotective effects in the body. Studying ApoM using proteomics requires various approaches to understand its expression, modifications, interactions, and functions in the proteome.

Learn more

WebinarUsing plasma proteomics to understand Alzheimer’s and other brain diseases

Dr. Walker discusses how he integrates proteomic, genetic, brain imaging and cerebral spinal fluid biomarkers from initially cognitively normal individuals who later develop dementia, in order to discover novel blood-based biomarkers and mechanistically relevant proteins for therapeutic target prioritization.

Learn more

WebinarProteomics for precision neuroscience: The power of protein analysis

This webcast highlights how academic, industry and government researchers are directly measuring protein abundance and function via multiplex proteomics to build more detailed characterizations of the biological systems underlying neurodegenerative diseases.

Learn more

Explore webinars in our interactive viewer